5AM Ventures — 2017 Investments

3 investments dated 2017 · listed companies and verified rows first · show all

Nouscomnouscom.comSeries B · Nov 2017 · $49M✓ verified

Nouscom is a biotech company whose investors page lists its venture capital backers.

BiotechHealthtech

Riccardo Cortese(Co-Founder)Marina Udier(Chief Executive Officer and Board Director)Elisa Scarselli(Chief Scientific Officer and Co-Founder)Alfredo Nicosia(Co-founder)Antonella Folgori(Co-founder)Stefano Colloca(Co-founder)

Co-investorsAndera Partners Angelini Ventures Revelation Partners XGEN Venture Bpifrance EQT Life Sciences +6 more

Homology Medicineshomologymedicines.com inJul 2017

Clinical-stage genetic medicines company using human-derived AAV vectors and nuclease-free gene editing for rare diseases.

BiotechBedford, US

Siyamak Rasty(Executive Officer)Albert Seymour(Executive Officer)

BoardSteven Gillis(Director)Arthur Tzianabos(Executive Officer, Director)Kush Parmar(Director)inRichard Gregory(Director)

Co-investorsARCH Venture Partners OUP (Osage University Partners)Alexandria Deerfield Management Company Fidelity Investments HBM Healthcare Investments +5 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Rennovia

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.